tirzepatide for obesity fda approval F.D.A. Approves New Drug That Will Compete With Wegovy #Zepbound (#tirzepatide aka #mounjaro) just
Description
It has a number of side effects, but the most severe include: Pancreatitis Gallbladder issues Increased risk of low blood sugar Kidney problems Changes in vision Increased heart rate Severe allergic reactions Saxenda Saxenda is another injectable drug by Novo Nordisk and is used to treat obesity in children and adults, as well as treat weight loss in adults
Can I split my tirzepatide dose (microdosing)
Fineman M, Flanagan S, Taylor K, et al
Gastroparesis (stomach paralysis) is a very serious medical condition that can lead to complications and even permanent injuries
Older adults may experience slower overall weight loss due to reduced metabolic rate and lean muscle mass

Start with one teaspoon daily and gradually increase to one tablespoon
